HanaokaSeishu, for article on Hanaoka Seishū general anesthesia

Hanaoka Seishū performs the first documented surgery under general anaesthesia

On a morning in October 1804 C.E., a 60-year-old woman named Kan Aiya drank a carefully prepared herbal mixture and drifted into unconsciousness. When she woke, a surgeon had removed part of her breast. She had felt nothing. The surgeon was Hanaoka Seishū, and what he accomplished that day is now recognized as the first reliably documented operation performed under general anesthesia in human history.

What the evidence shows

  • General anesthesia: Hanaoka’s formula, tsūsensan, produced unconsciousness and skeletal muscle paralysis through active compounds including scopolamine, hyoscyamine, atropine, aconitine, and angelicotoxin — a pharmacologically sophisticated result by any era’s standards.
  • Hanaoka Seishū: Born in 1760 C.E. in what is now Wakayama Prefecture, Hanaoka trained in both traditional Japanese medicine and Dutch-imported European surgery, synthesizing knowledge across two distinct medical traditions to develop his technique.
  • Tsūsensan formula: Documented in a 1796 C.E. pamphlet by his close colleague Shutei Nakagawa, the herbal anesthetic compound took Hanaoka roughly two decades of research and experimentation to perfect — research his wife assisted with at serious personal cost.

A quest that began with an ancient Chinese surgeon

Hanaoka did not arrive at his formula in isolation. Around 1785 C.E., he learned of Hua Tuo, a Chinese surgeon from the 2nd century C.E. who had reportedly performed major operations using a general anesthetic called mafeisan — a wine-dissolved herbal powder whose name roughly translates to “boiled cannabis powder.”

Hua Tuo’s technique was, by historical accounts, remarkable. But he burned his manuscripts before his death, and the exact composition of mafeisan was lost with him. Confucian teachings of the time discouraged surgery as a violation of the body’s sanctity, and the practice died out in China after Hua Tuo’s death. What remained were tantalizing descriptions in texts written long after the fact, with no reproducible formula.

Hanaoka read those descriptions and decided to reconstruct what had been lost. His approach drew on Chinese herbal pharmacology, Dutch medical texts available through Japan’s limited contact with the outside world via Rangaku — literally “Dutch learning” — and years of methodical experimentation. His wife, whose name history has not preserved as prominently as his own, volunteered as a test subject during those years and lost her sight as a result of the trials. The human cost of his research was real.

The compound, the surgery, and what followed

By 1796 C.E., Hanaoka’s research had advanced enough that his colleague Shutei Nakagawa wrote a pamphlet — titled “Mayaku-ko,” or “narcotic powder” — describing the current state of the work. That pamphlet, though its original was later destroyed in a fire, is the first documented record of what would become tsūsensan.

The compound itself was taken as a drink. After two to four hours, patients became insensible to pain and lost consciousness. Depending on dosage, they might remain unconscious for up to 24 hours — a window that allowed surgeons to work without haste or restraint.

Kan Aiya’s mastectomy in October 1804 C.E. was the proof. Hanaoka performed a partial removal of her breast for breast cancer — a procedure that, without anesthesia, would have required the patient to be fully conscious and physically restrained. Word spread quickly. Patients traveled from across Japan to seek his care. Before his death in 1835 C.E., Hanaoka performed more than 150 operations for breast cancer alone, as well as bladder stone extractions, amputations, and tumor resections. He also trained generations of students in what became known as the Hanaoka method.

Lasting impact

The idea that surgery need not mean agony — that a patient could sleep through the knife — is one of the most significant thresholds in the history of medicine. Hanaoka’s work proved it was achievable nearly four decades before Crawford Long used ether anesthesia in Jefferson, Georgia in 1842 C.E.

His pharmacological thinking was also ahead of its time. Tsūsensan’s active compounds — scopolamine and hyoscyamine in particular — are still used today in modified forms for anesthesia support, motion sickness, and surgical premedication. Hanaoka reached those compounds through empirical plant-based research, a tradition with deep roots in both Chinese and Japanese medicine.

The Japan Society of Anesthesiologists incorporated the Korean morning glory flower — a key ingredient in tsūsensan — into their official logo as a direct tribute to Hanaoka’s work. His preserved home in Kinokawa, Wakayama, now serves as a museum and educational site, adjacent to a nursing college.

His synthesis of traditions from different cultures — Chinese herbal pharmacology and Dutch surgical technique — also models something worth recognizing. The breakthrough was not the product of a single tradition working alone. It emerged from a surgeon who read across boundaries, in a country that had deliberately closed itself to the outside world.

Blindspots and limits

Because of Japan’s national isolation policy under the Tokugawa shogunate, Hanaoka’s achievements were unknown outside Japan until after the country opened in 1854 C.E. By that time, Western scientists had independently developed ether and chloroform anesthesia, and his work had no direct influence on those developments. His wife’s contribution to the research — including the loss of her sight — was real and significant, yet she remains largely unnamed in the historical record, a reminder of how often the people closest to discovery are the least documented. Tsūsensan itself was never widely adopted beyond his school, and its exact formulations varied among his students.

Read more

For more on this story, see: Wikipedia — Hanaoka Seishū

For more from Good News for Humankind, see:

About this article

  • 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
  • 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
  • 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
  • ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.

More Good News

  • African children smiling, for article on measles vaccination Africa

    Nearly 20 million measles deaths averted in Africa since 2000

    Measles vaccines in Africa have prevented an estimated 19.5 million deaths since 2000 — roughly 800,000 lives saved every year for nearly a quarter century. A new WHO and Gavi analysis credits steady investment in cold-chain systems, community health workers, and political will, with coverage for the critical second measles dose climbing more than tenfold over that stretch. This year, Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan nations to officially eliminate measles and rubella, a milestone once considered out of reach. The story is a powerful reminder that global health progress, though uneven, compounds quietly over decades —…


  • Trans pride flag during protest, for article on Romanian trans rights

    Romania finally recognizes trans man’s identity in landmark E.U. victory

    Romanian trans rights took a real leap forward this week, as courts finally ordered the government to legally recognize Arian Mirzarafie-Ahi as male — a recognition the U.K. granted him back in 2020. For years, he lived with two identities depending on which border he crossed, until his case climbed all the way to the E.U.’s top court and came home with a binding answer. That ruling now obligates every E.U. member state to honor gender recognition documents issued by another. It’s a quiet but powerful shift: transgender people across Europe gain stronger footing not through new laws, but through…


  • Old-growth tree, for article on Tongass rainforest logging ruling

    Alaska judge permanently shields Tongass old-growth forests from logging

    The Tongass National Forest just won a major day in court, with a federal judge ruling in March 2026 that the U.S. Forest Service is not legally required to ramp up logging to meet timber industry demand. The decision protects the world’s largest temperate old-growth rainforest — home to roughly a third of what remains of this ecosystem globally, along with wild salmon runs, brown bears, and trees older than 800 years. Tribal nations, fishing crews, and tourism operators stood alongside federal defenders in the case, a reminder that the forest’s value reaches far beyond timber. Wins like this give…



Coach, writer, and recovering hustle hero. I help purpose-driven humans do good in the world in dark times - without the burnout.